Abstract
The action mechanism of the betamimetics has been researched by ROBINSON, BUCHER and SUTHERLAND at the level of the cardiovascular system; intracellular adenyl-cyclase is activated. This enzyme catalyses ATP into AMPc, increased membrane potential hence increasing the threshold of excitability and inhibiting contractions. Similar effects occur in the uterus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Gardey, G., Serrano, J.J., Viala, J.L. (1975). Betamimetics and Placental Insufficiency Due to Uterine Hypoplasia. In: Salvadori, B. (eds) Therapy of Feto-Placental Insufficiency. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66008-5_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-66008-5_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66010-8
Online ISBN: 978-3-642-66008-5
eBook Packages: Springer Book Archive